Literature DB >> 23760680

Reply to Letter to the Editor: Inadequate methodology renders results on the use of tranexamic acid inconclusive.

Takao Iwai, Shigeyoshi Tsuji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23760680      PMCID： PMC3728392          DOI： 10.1007/s00264-013-1910-9

Source DB:  PubMed          Journal:  Int Orthop        ISSN： 0341-2695            Impact factor:   3.075


× No keyword cloud information.
  4 in total

1.  Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.

Authors:  Toshio Yamaguchi; Masahiro Hasegawa; Rui Niimi; Akihiro Sudo
Journal:  Thromb Res       Date:  2010-05-07       Impact factor: 3.944

2.  Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee.

Authors:  N Tanaka; H Sakahashi; E Sato; K Hirose; T Ishima; S Ishii
Journal:  J Bone Joint Surg Br       Date:  2001-07

3.  The efficacy of a single daily dose of enoxaparin for deep vein thrombosis prophylaxis following total knee arthroplasty.

Authors:  Pamela A Pulido; Steven N Copp; Richard H Walker; Lianette M Reden; Mary E Hardwick; Clifford W Colwell
Journal:  Orthopedics       Date:  2004-11       Impact factor: 1.390

4.  Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty.

Authors:  Takao Iwai; Shigeyoshi Tsuji; Tetsuya Tomita; Kazuomi Sugamoto; Yoshikawa Hideki; Masayuki Hamada
Journal:  Int Orthop       Date:  2013-02-01       Impact factor: 3.075
  4 in total
  1 in total

1.  The impact of mild peri-operative hypothermia on the effectiveness of tranexamic acid in total hip arthroplasty.

Authors:  Nicolas Reina; Peter Fennema; Hervé Hourlier
Journal:  Int Orthop       Date:  2016-03-23       Impact factor: 3.075
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.